findmyKOL
Clinical trialNCT06175000RecruitingPhase 2Interventional

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

SponsorProvidence Health & ServicesEnrollment28Primary Central Nervous System Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Christian Grommes, MD
    Not, yet, recruiting
  • Cleveland Clinic

    Cleveland, Ohio, United States

    David Peereboom, MD
    Not, yet, recruiting
  • Providence Health & Services; Providence Neurological Specialties

    Portland, Oregon, United States

    Prakash Ambady, MD
    Recruiting
  • Pennsylvania State University

    Hershey, Pennsylvania, United States

    Dawit Aregawi, MD
    Recruiting
  • University of Vermont

    Burlington, Vermont, United States

    Alissa Thomas, MD
    Recruiting
  • University of Virginia

    Charlottesville, Virginia, United States

    David Schiff, MD
    Recruiting
  • Ivy Center for Advanced Brain Tumor Treatment; Swedish Neuroscience Institute

    Seattle, Washington, United States

    Alipi Bomn, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Mar 2024
Primary completion
15 Sept 2028
Completion
15 Sept 2029
Last update posted
5 Jun 2025
Registered enrollment
28
Registry id
NCT06175000
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.